Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 2Wilms Tumor 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Retinoblastoma 1Glioma 1

Interventions

Vincristine 10Filgrastim 10Cyclophosphamide 10Doxorubicin 8Etoposide 7Radiotherapy 6Dactinomycin 6Carboplatin 6Granulocyte Colony-Stimulating Factor 5Topotecan 4Polymerase Chain Reaction 4Gene Expression Profiling 4sargramostim 3Temozolomide 3Reverse Transcriptase Polymerase Chain Reaction 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Itraconazole 3Irinotecan 3Ifosfamide 3DNA Methylation 3Cisplatin 3Busulfan 3liposomal amphotericin B 2ixabepilone 2X-Rays 2Voriconazole 2Therapeutics 2Stem Cell Transplantation 2Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Wilms Tumor × racotumomab × Clear all
NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed
15 enrolled
CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡